RecruitingACTRN12608000499381

Chlamydia Prevalence and Testing Project - a randomised controlled trial

Chlamydia prevalence and testing program targetting women aged 16 to 24 years in general practice


Sponsor

University of Melbourne

Enrollment

12 participants

Start Date

May 15, 2008

Study Type

Interventional

Conditions

Summary

To determine whether a $5 incentive payment will lead to increased chlamydia testing rates by general practitioners.


Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This study is aimed at general practice (GP) clinics, not individual patients. Researchers are testing whether offering GPs a small financial incentive of $5 per test increases how often they test young women (aged 16–24) for chlamydia, a very common sexually transmitted infection that often has no symptoms. Early detection and treatment of chlamydia is important for preventing complications. The study measures testing rates across different clinics. You may be eligible if: - You are a GP clinic (not an individual patient) - The clinic sees more than 250 women aged 16–24 per year - The clinic has at least 2 full-time equivalent GPs - The clinic uses an electronic medical records system You may NOT be eligible if: - The clinic sees fewer than 250 women aged 16–24 per year Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The in

The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The intervention will be in place for 6 months. GPs will be expected to conduct chlamydia screening during a routine consultation with an eligible patient. Screening involves requesting a chlamydia test for the patient. It should take a couple of minutes to discuss with the patient during the consultation


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000499381